Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RASSTER: Switching Lopinavir/Ritonavir to Raltegravir in HIV
NCT01453933Phase 4Unknown
- Start
- Jan 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV). Status: unknown.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01453933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01453933.